Point72 Middle East FZE’s Veracyte VCYT Stock Holding History

Point72 Middle East FZE’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,936	Closed	-$603K	–	1270
2023 Q4	$603K	Sell	21,936 -4,544	-17%	-$110K	0.02%	761
2023 Q3	$591K	Buy	26,480 +1,109	+4%	+$28.5K	0.02%	754
2023 Q2	$646K	Buy	+25,371	New	+$615K	0.02%	707

Other funds holding VCYT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Point72 Middle East FZE's VCYT Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 21,936 shares — an estimated $603K sold.

Point72 Middle East FZE first reported a position in VCYT in Q2 2023 and held it in 3 quarters. The position peaked at $646K in Q2 2023. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

Point72 Middle East FZE reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
Point72 Middle East FZE sold 21,936 Veracyte shares in Q1 2024, an estimated $603K.
Point72 Middle East FZE first reported a position in Veracyte in Q2 2023 and held it in 3 quarters.
Point72 Middle East FZE's Veracyte position peaked at $646K in Q2 2023.
246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.